Showing results (131-140 of 177) with videos related to

Sort By:
Pageof 18
Japanese Journal of Clinical Oncology|December 26, 2025
Real-world efficacy of switching androgen receptor signaling inhibitor therapy following apalutamide discontinuation because of adverse events in advanced prostate cancer: a multicenter studyYoichiro Tohi, Takuma Kato, Kengo Fujiwara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 20, 2022
Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN studyTakuma Kato, Akira Yokomizo, Ryuji Matsumoto, et al.
BJU International|April 14, 2025
Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatmentIvo I de Vos, Cristina Marenghi, Fabio Badenchini, et al.
World Journal of Urology|October 20, 2020
Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPANHiromi Hirama, Mikio Sugimoto, Nobuyuki Miyatake, et al.
Japanese Journal of Clinical Oncology|January 22, 2021
External validation of the albumin, C-reactive protein and lactate dehydrogenase model in patients with metastatic renal cell carcinoma receiving second-line axitinib therapy in a Japanese multi-center cohortKeita Tamura, Takahiro Osawa, Ario Takeuchi, et al.
European Urology Oncology|October 9, 2024
Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel TrialNoel W Clarke, Andrew J Armstrong, Mototsugu Oya, et al.
International Journal of Clinical Oncology|July 27, 2021
Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomyKota Iida, Makito Miyake, Kaoru Murakami, et al.
International Journal of Clinical Oncology|October 2, 2021
Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN studyYoichiro Tohi, Takuma Kato, Masaki Nakamura, et al.
Japanese Journal of Clinical Oncology|October 16, 2023
Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological ConsortiumYoichiro Tohi, Takuma Kato, Keita Kobayashi, et al.
Japanese Journal of Clinical Oncology|July 27, 2023
Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohortYoichiro Tohi, Ryou Ishikawa, Takuma Kato, et al.
Pageof 18